Psomagen, Inc.

950200KOSDAQOther scientific and technical services

Psomagen, Inc. (950200, KOSDAQ) reported KRW 0bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
20230-0-000Consolidated
20240-0-000Consolidated
20250-0-000Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2023-11%-13.6%72.3%-13.5%
2024-12%-14.3%54.6%-22.2%
2025-3.8%-7%51.7%-16.2%

Revenue moved 68.3% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 62bn
Close priceKRW 3,230
Listed shares19,236,053
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)88
Women46 (52.3%)
Average tenure3.7 years
Annual pay, menKRW 89,770,238
Annual pay, womenKRW 68,424,478
Pay ratio, women to men76.2%

Other companies in Other scientific and technical services

18 listed companies file under this classification. Showing 12.

See the whole Other scientific and technical services list →